[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100625837":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":11,"locations":11,"responsibleParty":20,"collaborators":11,"id":22,"slug":23,"hasResults":24,"nctId":25,"briefTitle":26,"officialTitle":27,"acronym":11,"eligibilityCriteria":28,"healthyVolunteers":24,"sex":29,"minAge":30,"maxAge":11,"enrollmentInfo":31,"targetDuration":11,"studyType":34,"phases":35,"briefSummary":37,"conditions":38,"keywords":11,"overallStatus":40,"whyStopped":11,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":11},{"fullName":5,"class":6},"Microsure","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Robot-assisted anastomoses","EXPERIMENTAL",null,[13],"Device: Robot-assisted microsurgical anastomoses",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DEVICE","Robot-assisted microsurgical anastomoses","First in human study",[9],{"type":21,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100625837","evaluation-of-musa-3-in-microsurgical-anastomoses-100625837",false,"NCT07427823","Evaluation of MUSA-3 in Microsurgical Anastomoses","Clinical Safety and Performance Evaluation of MUSA-3 in Microsurgical Anastomoses","Inclusion Criteria:\n\n* Patient age ≥ 18 years.\n* Patients requiring procedures involving micro-anastomosis of small anatomical structures-such as blood vessels, nerves, or lymphatic vessels-in free flap, lymphatic, or peripheral nerve surgery.\n* Patients who have been selected by the research team at the Clinical Center as appropriate candidates for treatment with MUSA-3 in accordance with the IFU.\n* Able to give informed consent before participating in the study.\n* Provision of signed and dated informed consent form.\n\nExclusion Criteria:\n\n* Subject participates in a potentially confounding drug or device trial during the course of the study.\n* Patients that are pregnant or breastfeeding.\n\nFor Lymphedema patients:\n\n* ≥ISL (International Society of Lymphology) Stage III lymphedema\n* History of marcaine or indocyanine green allergy\n* Non-viable lymphatic system as determined by ICG lymphatic mapping using near infrared camera","ALL","18 Years",{"count":32,"type":33},30,"ESTIMATED","INTERVENTIONAL",[36],"NA","This study is conducted to evaluate the safety and performance of robot-assisted microsurgical anastomoses with the MUSA-3 system.",[39],"Anastomosis, Surgical","NOT_YET_RECRUITING","2026-02-16",{"date":43,"type":44},"2026-02-23","ACTUAL",{"date":46,"type":33},"2026-04-20",{"date":48,"type":33},"2026-09-28",{"name":5,"class":6}]